RxDoctor Payments Data

Jack Rowland, MD

Obstetrics & Gynecology · Chattanooga, TNNPI 1417970054

Payments from drug & device makers

$7,327in general payments, 2019–2025

Across 165 payments — averaging $44.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$3K
  • Mimedx Group, Inc.$1K
  • Mayne Pharma Commercial LLC$350
  • Astellas Pharma US Inc$350
  • Sage Therapeutics, LLC$308
  • Sumitomo Pharma America, Inc.$267
  • plus $2K from 34 others

What the payments were for

  • Consulting fees$1,20016%
  • Travel & lodging$6178%
  • Food & beverage$3,51048%
  • Education$2,00027%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,327 in reported general payments places this provider in the 90th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$50,296
Medicare patients
221
Services billed
506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized213$11,051
Estradiol176$6,625
MyrbetriqMirabegron14$6,171
Estradiol (Twice Weekly)Estradiol52$4,443
DottiEstradiol16$1,685
Estradiol Valerate15$1,441
ValacyclovirValacyclovir Hcl32$1,040
Oxybutynin Chloride ErOxybutynin Chloride28$898
Liothyronine Sodium17$514
Medroxyprogesterone Acetate22$501
Spironolactone25$436
Fluconazole44$263
Testosterone Cypionate21$253
Levothyroxine Sodium14$117
Ibuprofen17$51

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$350$6,17114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 763 obstetrics & gynecology providers in Tennessee.

Other obstetrics & gynecology in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →